Issue No. 2012
New Appointments & Arrivals
Date: December 20, 2011
Roisin M. Connolly, M.B., BCh, B.A.O., M.R.C.P.I., has joined the Breast Cancer program as an assistant professor of oncology. She graduated with first class honors from the Medical School in Trinity College, Dublin, Ireland where she received the Sir James Craig Memorial Prize for first place in Medicine. She also was awarded the prestigious Reuben Harvey Prize by the Royal College of Physicians in Ireland for first place nationally in Medicine, Surgery and Obstetrics. At the Kimmel Cancer Center, she will focus on drug development and clinical trial design, and will establish a continuity outpatient clinic where she will see patients with breast cancer.
Russell Hales, M.D., has joined the Department of Radiation Oncology and Molecular Radiation Sciences as an instructor. He is focusing on clinical and research efforts in thoracic malignancies, including developing a thoracic multidisciplinary clinic and participating in the development of the Lung Cancer Center of Excellence at Johns Hopkins Bayview. His research interests include novel radiation sensitizers in non-small cell lung cancer and characterization of organ motion in thoracic tumors.
Danijela Jelovac, M.D., was appointed an assistant professor of oncology. Danijela is a clinical investigator specializing in women’s cancers, most specifically, breast and female reproductive cancers. She has joined the Kimmel Cancer Center as an assistant professor of oncology and will treat patients primarily at our Bayview campus. She completed a postdoctoral research fellowship with aromatase inhibitor expert Angela Brodie, Ph.D, at the University of Maryland and recently finished her fellowship at the Kimmel Cancer Center, working with Dr. Deborah Armstrong and other members of our Breast Cancer Program.
Ronan J. Kelly, M.D., has joined the Upper Aerodigestive Program as an assistant professor of oncology. He was recruited from the National Cancer Institute (NCI) where he was a thoracic oncology clinical investigator, writing and directing a number of innovative investigator-initiated clinical trials. In addition to his work at NCI, Kelly served for two years as the Medical Director at Roche Pharmaceuticals in Ireland. At the Kimmel Cancer Center, he will continue his research in lung cancer and cancers of the thymus gland and tissue and begin researching esophageal cancer.
Jenny Kim, M.D, instructor in oncology, is a new member of the Genitourinary Cancer Program and will focus on developing a clinical research program, including personalized medicine strategies, for kidney and bladder cancers. Her research accomplishments include work with Dr. Brian Rini, an international expert on kidney cancer drug development.
Evan J. Lipson, M.D., will be working in cancer immunology as a new Instructor in Oncology. His long-term goal is to develop translational clinical strategies to treat melanoma, focusing on immunotherapies, including melanoma vaccines and immune-modulating monoclonal antibodies, and molecularly targeted agents. He was selected to be the Chief Fellow in 2010 and has spent the past two years training in clinical research in melanoma with Drs. William Sharfman and Suzanne Topalian.
Eric Raabe, M.D., Ph.D., an instructor in oncology in the Division of Pediatric Oncology, will work as a physician-scientist focusing on pediatric brain tumor research and treatment. After spending a year working in Africa as part of the Baylor International Pediatric AIDS Initiative, he came to Johns Hopkins as a pediatric oncology fellow. Working in the laboratory of Dr. Charles Eberhart in Neuropathology, Raabe successfully established a human neural stem cell system to create genetically accurate models of pediatric brain tumors. He will continue his research and will also work closely with Dr. Kenneth Cohen, Clinical Director of Pediatric Oncology and brain tumor expert.
Rachel Rau, M.D., is a new member of the Pediatric Oncology Program. A physician-scientist, she will focus on translational childhood leukemia research. She completed her residency and fellowship at Johns Hopkins and was selected as chief resident of the Hopkins pediatric residency program and chief fellow of the Hopkins/NIH pediatric oncology fellowship program. Rau has been conducting research in the laboratory of pediatric oncology leukemia expert Dr. Patrick Brown and will continue to study the unique biology of leukemias with the aim of identifying new therapeutic targets.
Zeshaan Rasheed, M.D., Ph.D., has joined the Gastro-intestinal Cancer Program as an assistant professor of oncology. He recently completed his medical oncology fellowship at the Kimmel Cancer Center and was recruited to develop a translational laboratory program focused on pancreatic cancer stem cells and their role in pancreatic cancer development and progression. His fellowship work in the laboratory of William Matsui, last year earned him recognition as the first and only recipient of the new AACR “Pathway to Leadership” award in pancreatic cancer in 2010. In addition, he was named a Viragh Clinical Research Scholar and will continue to participate in the Pancreatic Multidisciplinary Clinic, the outpatient clinic and inpatient service.
Kristin Redmond, M.D., M.P.H., instructor in oncology, has the joined the Department of Radiation Oncology and Molecular Radiation Sciences. She is a member of the Stereotactic Spine Program and focuses on diseases of the spine and central nervous system.
Dipali Sharma, Ph.D., associate professor of oncology, is a new member of our Breast Cancer Program. She is a leading translational scientist in the field of obesity and cancer research and will lead the Center’s research efforts to further understand the connection between obesity and cancer and develop prevention strategies. Her work focuses on the molecular and hormonal mechanisms underlying the obesity-cancer connection, and she has established important links between adipocytokines (cell-to-cell signaling proteins secreted by body fat) and cancer progression.
Thomas Smith, an international leader in the field of palliative care, has been named the director of Palliative Care for Johns Hopkins Medicine and the inaugural Harry J. Duffey Family Professor of Palliative Care in the Department of Oncology. He will lead palliative care efforts throughout Johns Hopkins, including the Kimmel Cancer Center. His research focuses on neuropathic pain, care at the end of life, and bending the cost curve in patients with life-limiting conditions.
Chenguang Wang, Ph.D., has been appointed an assistant professor of oncology in the Division of Biostatistics and Bioinformatics. As a statistician, he has a strong background in oncologic clinical research, particularly in clinical trials and observational studies. His current research focuses on the analysis of longitudinal data subject to “missingness,” or where there are missing values in data. Before joining Johns Hopkins and completing his doctorate, he was a statistician with the Children’s Oncology Group’s (COG) Statistics and Data Center at the University of Florida and the Center for Devices and Radiological Health at the U.S. Food and Drug Administration.